PIMJS
PKO Investment Management Joint-Stock Portfolio holdings
AUM
$931M
This Quarter Return
-5.12%
1 Year Return
+16.38%
3 Year Return
+65%
5 Year Return
+112.48%
10 Year Return
+522.82%
AUM
$590M
AUM Growth
+$590M
(-15%)
Cap. Flow
-$52.1M
Cap. Flow
% of AUM
-8.83%
Top 10 Holdings %
Top 10 Hldgs %
49.42%
Holding
141
New
15
Increased
21
Reduced
59
Closed
7
Top Buys
| 1 |
Tesla
TSLA
|
$5.94M |
| 2 |
Agnico Eagle Mines
AEM
|
$5.52M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$4.93M |
| 4 |
Salesforce
CRM
|
$3.16M |
| 5 |
Newmont
NEM
|
$2.98M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$23.6M |
| 2 |
NexGen Energy
NXE
|
$4.42M |
| 3 |
Gold Fields
GFI
|
$4.4M |
| 4 |
Teck Resources
TECK
|
$4.18M |
| 5 |
Sibanye-Stillwater
SBSW
|
$4.03M |
Sector Composition
| 1 | Technology | 15.12% |
| 2 | Materials | 14.57% |
| 3 | Energy | 9.81% |
| 4 | Healthcare | 8.13% |
| 5 | Consumer Discretionary | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Coterra Energy
CTRA
$18.7B
| $757K | 0.13% |
+29,000
| New | +$757K |
|
102
Intuitive Surgical
ISRG
$170B
| $750K | 0.13% |
4,000
-2,000
| -33% | -$375K |
|
|
MRO
103
DELISTED
Marathon Oil Corporation
MRO
| $677K | 0.11% |
+30,000
| New | +$677K |
|
104
Becton Dickinson
BDX
$55.3B
| $668K | 0.11% |
3,000
| – | – |
|
105
Boston Scientific
BSX
$156B
| $658K | 0.11% |
17,000
| – | – |
|
106
Bunge Global
BG
$16.8B
| $651K | 0.11% |
7,890
+4,500
| +133% | +$372K |
|
107
Tapestry
TPR
$21.2B
| $625K | 0.11% |
22,000
-23,000
| -51% | -$654K |
|
108
Edwards Lifesciences
EW
$47.8B
| $595K | 0.1% |
7,200
| – | – |
|
109
Topgolf Callaway Brands
MODG
$1.76B
| $578K | 0.1% |
30,000
| – | – |
|
110
Carnival Corp
CCL
$43.2B
| $562K | 0.1% |
80,000
| – | – |
|
111
Gilead Sciences
GILD
$140B
| $555K | 0.09% |
9,000
-5,000
| -36% | -$308K |
|
112
Agilent Technologies
A
$35.7B
| $511K | 0.09% |
4,200
| – | – |
|
113
PVH
PVH
$4.05B
| $448K | 0.08% |
10,000
| – | – |
|
114
IQVIA
IQV
$32.4B
| $417K | 0.07% |
2,300
| – | – |
|
115
Regeneron Pharmaceuticals
REGN
$61.5B
| $413K | 0.07% |
600
-600
| -50% | -$413K |
|
116
Compañía de Minas Buenaventura
BVN
$4.86B
| $397K | 0.07% |
58,942
| – | – |
|
117
Hudbay
HBM
$4.75B
| $386K | 0.07% |
94,836
-956,864
| -91% | -$3.89M |
|
|
118
NexGen Energy
NXE
$4.5B
| $379K | 0.06% |
103,300
-1,205,000
| -92% | -$4.42M |
|
119
Baxter International
BAX
$12.7B
| $377K | 0.06% |
7,000
| – | – |
|
120
Biogen
BIIB
$19.4B
| $374K | 0.06% |
1,400
| – | – |
|
121
Idexx Laboratories
IDXX
$51.8B
| $358K | 0.06% |
1,100
| – | – |
|
122
Moderna
MRNA
$9.37B
| $355K | 0.06% |
3,000
-171
| -5% | -$20.2K |
|
123
Vertex Pharmaceuticals
VRTX
$100B
| $347K | 0.06% |
1,200
| – | – |
|
|
CGAU
124
Centerra Gold
CGAU
$1.66B
| $329K | 0.06% |
74,000
-100,000
| -57% | -$445K |
|
|
125
Sibanye-Stillwater
SBSW
$5.36B
| $324K | 0.05% |
34,744
-432,000
| -93% | -$4.03M |
|